Biotech/Pharma Startup Financial Models

Biotech and pharma startup financial model examples in Excel, covering research pipelines, clinical milestones, pharmacy revenue, and funding needs. Explore revenue forecasts, operating costs, and the cash needed to grow.

moderna_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Moderna logo

Moderna

$500.0M raised

mRNA-based drug platform company using messenger RNA as programmable "software" to instruct cells to produce therapeutic proteins.

transcarent_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Transcarent logo

Transcarent

$200.0M raised

Consumer-directed digital health platform connecting employer-covered members to high-value care across telehealth, surgery, pharmacy, and specialty services.

beckley-psytech_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Beckley Psytech logo

Beckley Psytech

$186.0M raised

Clinical-stage psychedelic drug development platform advancing a pipeline of psychedelic compounds (psilocybin, 5-MeO-DMT, NCEs) as licensed pharmaceutical medicines for neuropsychiatric disorders.

deep-genomics_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Deep Genomics logo

Deep Genomics

$180.0M raised

AI-driven RNA therapy platform that uses machine-learning predictors to discover and design genetic medicines for rare and complex diseases.

affini-t_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
AF

Affini-T

$175.0M raised

Engineered T cell therapies targeting oncogenic driver mutations (KRAS, p53) in hard-to-treat solid tumors

every_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
EVERY logo

EVERY

$175.0M raised

Precision fermentation company producing real animal proteins (egg proteins, pepsin) without animals, targeting food ingredients market.

aurion-biotech_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Aurion Biotech logo

Aurion Biotech

$120.0M raised

Cell therapy company developing an injectable corneal endothelial cell treatment to restore vision in patients with corneal endothelial disease.

ilobby_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
iLobby logo

iLobby

$100.0M raised

Enterprise Visitor Management (EVM) SaaS platform that digitises, screens, and monitors physical access across facilities for regulated industries.

ada-health_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Ada Health logo

Ada Health

$90.0M raised

AI-powered symptom assessment app and clinical decision-support platform for consumers and healthcare partners.

compass-pathways_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Compass Pathways logo

Compass Pathways

$80.0M raised

Clinical-stage biotech developing psilocybin therapy for treatment-resistant depression (TRD), seeking regulatory approval in EU, US, and Canada.

apheabio_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Aphea.Bio logo

Aphea.Bio

$70.0M raised

Aphea.Bio is a Belgian ag-biotech company developing and commercialising microbial biologicals (biostimulants, biofungicides, bioherbicides, bioinsecticides) for row crops, targeting yield improvement and reduced synthetic input use.

supercom_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Super.com logo

Super.com

$60.0M raised

Super is a savings super app targeting low-income Americans, offering hotel discounts, cashback rewards (SuperCash), credit building, gas savings, phone plans, insurance, and pharmacy deals in one app.

carrum-health_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
CH

Carrum Health

$45.0M raised

Value-based care marketplace connecting self-insured employers to top-tier surgical and oncology Centers of Excellence (COEs) via all-inclusive bundled payments.

castor_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Castor logo

Castor

$45.0M raised

SaaS platform enabling self-service decentralized clinical trials (DCT) for pharma, biotech, and research institutions.

brightinsight_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
BrightInsight logo

BrightInsight

$40.0M raised

Regulated digital health platform-as-a-service for biopharma and medtech companies to build, launch, and maintain compliant connected-drug and medical-device software products.

super-coffee_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
SC

Super Coffee

$25.0M raised

KITU Life makes better-for-you RTD coffee, espresso shots, and coffee creamer - zero sugar, protein-enhanced, MCT oil-fortified - targeting health-conscious consumers dissatisfied with sugary mainstream options.

multus-media_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Multus Media logo

Multus Media

$21.0M raised

B2B supplier of animal-free cell culture growth media (serum substitutes) for the cultivated meat industry.

clearing_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Clearing logo

Clearing

$20.0M raised

D2C telehealth platform delivering personalized, opioid-free chronic pain treatment via prescription compound creams shipped to patients' doors.

dutch_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Dutch logo

Dutch

$20.0M raised

Dutch is a pet telehealth platform offering online vet consultations, prescription treatment plans, and D2C medication delivery for dogs and cats with chronic conditions.

equinom_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
Equinom logo

Equinom

$20.0M raised

Equinom develops genetically optimised ("smarter") seeds for plant-based protein crops, enabling food manufacturers to skip expensive factory processing by doing the work in the field.

vira-health_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
VH

Vira Health

$12.0M raised

Digital menopause care platform ("Stella") combining a personalised 12-week behaviour-change app with 1:1 coaching, community, and a roadmap to add telemedicine and pharmaceutical prescription/delivery.

phagelab_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
PhageLab logo

PhageLab

$11.0M raised

AI-powered bacteriophage platform that replaces failing antibiotics in animal (and eventually human) health by developing custom phage cocktails in 45 days.

space-forge_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
SF

Space Forge

$10.0M raised

In-space manufacturing company building fully returnable and re-launchable satellite platforms (ForgeStar™) to produce materials impossible to make on Earth.

troy-medicare_Financial_Model.xlsx
Metric
2026
2027
Revenue
--
--
EBITDA
--
--
TM

Troy Medicare

$10.0M raised

Medicare Advantage health plan that acquires members through independent community pharmacies at near-zero CAC.

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview